Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05147519

Protocol RV 583 Multinational Observational Cohort of HIV and Other Infections

Multinational Observational Cohort of HIV and Other Infections (MOCHI)

Status
Recruiting
Phase
Study type
Observational
Enrollment
2,500 (estimated)
Sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine · Academic / Other
Sex
All
Age
14 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Multinational Observational Cohort of HIV and other Infections (MOCHI). This observational study is to gain information regarding the number of new HIV infections among people who engage in behaviors that make them vulnerable to acquiring HIV across multiple international sites.

Detailed description

Prospective observational cohort study of participants vulnerable to HIV, conducted in three Steps. Step 1 will enroll participants aged 14-55 years who are vulnerable to contracting HIV. They will be evaluated every 12 weeks for HIV and other sexually transmitted infections (STIs). Participants who are diagnosed with HIV will proceed to Step 2, with evaluation of viral load and other HIV-related tests every four weeks for 12 weeks and then every 12 weeks for a total of 48 weeks. Participants who achieve and maintain viral suppression in Step 2 will proceed to Step 3 for continued HIV monitoring every 24 weeks to document maintenance of viral suppression and maintain engagement with the study site for potential future recruitment into interventional studies, including clinical trials of novel strategies to achieve HIV remission.

Conditions

Interventions

TypeNameDescription
BEHAVIORALNovel interventions to achieve HIV remissionTo establish a group of well-characterized people living with HIV who initiated ART during acute or early HIV transmission that can serve as a source population for future studies, including those designed to test novel interventions to achieve HIV remission.

Timeline

Start date
2021-11-05
Primary completion
2027-06-30
Completion
2032-06-30
First posted
2021-12-07
Last updated
2025-03-06

Locations

3 sites across 3 countries: Kenya, Philippines, Uganda

Source: ClinicalTrials.gov record NCT05147519. Inclusion in this directory is not an endorsement.